Discover
RCUS
Arcus Biosciences, Inc.
28.91
18 x 28.84
1 x 28.87
bid
ask
+
0.19
0.66%
01:32 PM
timesize
| Ytd | 21.32% | |
| 1y | 215.61% |
27.95
day range
28.92
9.22
52 week range
31.73
| Open | 28.74 | Prev Close | 28.72 | Low | 27.95 | High | 28.92 | Mkt Cap | 3.63B |
| Vol | 333.18K | Avg Vol | 1.24M | EPS | -3.90 | P/E | -7.40 | Forward P/E | -8.80 |
| Beta | 0.80 | Short Ratio | 8.15 | Inst. Own | 73.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 27.35 | 200-d Avg | 23.62 | 1yr Est | 38.00 |
| Income Statement | |||
| Total Revenue | 41.00M | ||
| Revenues (USD) | 41.00M | ||
| Gross Profit | 41.00M | ||
| Operating Expenses | 137.00M | ||
| Research and Development Expense | 113.00M | ||
| Selling, General and Administrative Expense | 24.00M | ||
| Operating Income | -96.00M | ||
| Interest Expense | 3.00M | ||
| Net Income | -91.00M | ||
| Net Income Common Stock | -91.00M | ||
| Net Income Common Stock (USD) | -91.00M | ||
| Consolidated Income | -91.00M | ||
| Earnings per Basic Share | -0.72 | ||
| Earnings per Basic Share (USD) | -0.72 | ||
| Earnings per Diluted Share | -0.72 | ||
| Earning Before Interest & Taxes (EBIT) | -88.00M | ||
| Earning Before Interest & Taxes (USD) | -88.00M | ||
| Weighted Average Shares | 126.10M | ||
| Weighted Average Shares Diluted | 126.10M | ||
| Balance Sheet | |||
| Cash and Equivalents | 150.00M | ||
| Cash and Equivalents (USD) | 150.00M | ||
| Investments | 625.00M | ||
| Investments Current | 552.00M | ||
| Investments Non-Current | 73.00M | ||
| Trade and Non-Trade Receivables | 36.00M | ||
| Current Assets | 756.00M | ||
| Property, Plant & Equipment Net | 36.00M | ||
| Total Assets | 924.00M | ||
| Total Debt | 101.00M | ||
| Current Liabilities | 198.00M | ||
| Debt Non-Current | 101.00M | ||
| Total Liabilities | 460.00M | ||
| Accumulated Retained Earnings (Deficit) | -1.70B | ||
| Accumulated Other Comprehensive Income | -1000.00K | ||
| Shareholders Equity | 464.00M | ||
| Shareholders Equity (USD) | 464.00M | ||
| Assets Non-Current | 168.00M | ||
| Total Debt (USD) | 101.00M | ||
| Deferred Revenue | 56.00M | ||
| Liabilities Non-Current | 262.00M | ||
| Trade and Non-Trade Payables | 34.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.00M | ||
| Net Cash Flow from Financing | 16.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -51.00M | ||
| Issuance (Purchase) of Equity Shares | 16.00M | ||
| Net Cash Flow from Investing | 52.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 52.00M | ||
| Net Cash Flow from Operations | -119.00M | ||
| Share Based Compensation | 15.00M | ||